SPHK1 and neoplasm: Importantly, treatment of shSK1 B16 tumor-bearing mice with liposome encapsulated clodronate, a macrophage-depleting agent, abrogated tumor growth reduction induced by SK1 knockdown, suggesting that this effect is dependent on macrophages (Figure 2B).